Pier Capital, LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 164 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2013. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q4 2014$6,557,000
-4.7%
194,756
-0.8%
0.97%
-11.5%
Q3 2014$6,877,000
+5.4%
196,369
-1.1%
1.10%
+18.8%
Q2 2014$6,527,000
-18.4%
198,620
-8.5%
0.93%
-10.1%
Q1 2014$7,999,000
-4.5%
217,001
-0.6%
1.03%
-7.8%
Q4 2013$8,376,000
+10.7%
218,228
-20.9%
1.12%
+4.7%
Q3 2013$7,563,000276,0281.07%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders